Effectiveness and safety of biosimilars in pediatric inflammatory bowel diseases: an observational longitudinal study on the French National Health Data System.

Jourdain H, Hoisnard L, Sbidian E, Zureik M

Open source

DOI
10.1007/s12519-024-00873-4
Published
2025 Jan
Container
World journal of pediatrics : WJP
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12519-024-00873-4,
  title = {Effectiveness and safety of biosimilars in pediatric inflammatory bowel diseases: an observational longitudinal study on the French National Health Data System.},
  author = {Jourdain H and Hoisnard L and Sbidian E and Zureik M},
  year = {2025},
  journal = {World journal of pediatrics : WJP},
  doi = {10.1007/s12519-024-00873-4},
  url = {https://doi.org/10.1007/s12519-024-00873-4}
}

RIS

TY  - JOUR
TI  - Effectiveness and safety of biosimilars in pediatric inflammatory bowel diseases: an observational longitudinal study on the French National Health Data System.
AU  - Jourdain H
AU  - Hoisnard L
AU  - Sbidian E
AU  - Zureik M
PY  - 2025
JO  - World journal of pediatrics : WJP
DO  - 10.1007/s12519-024-00873-4
UR  - https://doi.org/10.1007/s12519-024-00873-4
ER  - 

APA

H, J., L, H., E, S., & M, Z. (2025). Effectiveness and safety of biosimilars in pediatric inflammatory bowel diseases: an observational longitudinal study on the French National Health Data System.. World journal of pediatrics : WJP. https://doi.org/10.1007/s12519-024-00873-4

Source records